abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Diese Seite ist nicht auf Deutsch verfügbar und wird angezeigt auf English

Artikel

12 Aug 2024

Autor:
Elijah Pittman, Maryland Matters

USA: Baltimore reaches $45 million settlement with CVS in opioid litigation

"Baltimore wins another $45 million from a drug company in opioid litigation," 12 August 2024

Baltimore has reached a second $45 million settlement in its lawsuit against multiple pharmaceutical companies and drug stores for their part in the city’s opioid crisis.

The agreement... with CVS comes two months after the city reached a similar agreement with Allergan Finance...

CVS denies any wrongdoing in the settlement, which has resolved all city claims against the drug chain, said Michael Deangelis, the executive director of corporate communications for CVS.

“CVS will no longer be a defendant in the city’s opioid distribution lawsuit that is scheduled for trial in September 2024. Putting these claims behind us is in the best interest of all parties and the agreement does not constitute an admission of wrongdoing,” Deangelis said in a statement to Maryland Matters...

Zeitleiste

Informationen zum Datenschutz

Diese Website verwendet Cookies und andere Web-Speichertechnologien. Sie können Ihre Datenschutzeinstellungen unten festlegen. Die Änderungen werden sofort wirksam.

Weitere Informationen über unsere Nutzung von Webspeicherung finden Sie in unserer Richtlinie zur Datennutzung und Cookies

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Analytics-Cookie

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

Ihre Privatsphäre-Einstellungen für diese Website

Diese Website verwendet Cookies und andere Web-Speichertechnologien, um Ihre Erfahrung über die notwendigen Kernfunktionen hinaus zu verbessern.